Reduction of Demoralization After Treatment of TD With Valbenazine

Status Not yet recruiting

Clinical Trial Summary

The purpose of this research project is to determine the feasibility of a larger study aimed at demonstrating that treatment of tardive dyskinesia with Valbenazine is associated with reduction of demoralization

Clinical Trial Description

This will be an Investigator-initiated, prospective, single center, interventional pilot study. This study will examine the feasibility of a larger study aimed at determining if there is an association between the improvement in tardive dyskinesia and the reduction in demoralization and subjective incompetence in patients with tardive dyskinesia after treatment with Valbenazine. Participants will be treated with Valbenazine for a total of 7 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05053321
Study type	Interventional
Source	Yale University
Contact
Status	Not yet recruiting
Phase	Phase 1
Start date	April 2024
Completion date	July 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02840760` - Repetitive Transcranial Magnetic Stimulation for the Treatment of the Tardive Dyskinesia.	N/A
Completed	`NCT01688037` - NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)	Phase 2
Completed	`NCT01391390` - Melatonin Treatment for Tardive Dyskinesia in Schizophrenia	N/A
Withdrawn	`NCT03254186` - Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia	Phase 2/Phase 3
Completed	`NCT02291861` - Addressing Involuntary Movements in Tardive Dyskinesia	Phase 3
Completed	`NCT02274558` - A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia	Phase 3
Completed	`NCT02198794` - Reducing Involuntary Movements in Participants With Tardive Dyskinesia	Phase 3
Completed	`NCT01467089` - The Assessment of Movement Disorders Utilizing Live Two-Way Video	N/A
Completed	`NCT04794413` - Pimavanserin Treatment in TS	Early Phase 1
Recruiting	`NCT06011408` - Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes	N/A
Recruiting	`NCT05859698` - Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia	Phase 4
Active, not recruiting	`NCT02252380` - ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders	N/A
Terminated	`NCT00917293` - Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia	Phase 2
Completed	`NCT01543321` - Xenazine in Late Dyskinetic Syndrome With Neuroleptics	Phase 3
Completed	`NCT02405091` - Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia	Phase 3
Completed	`NCT03176771` - Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia	Phase 2/Phase 3
Terminated	`NCT02524886` - Deep Brain Stimulation for Patients With Tardive Dyskinesia and or Dystonia	N/A
Completed	`NCT02195700` - Aim to Reduce Movements in Tardive Dyskinesia	Phase 2/Phase 3
Completed	`NCT02736955` - Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia	Phase 3
Completed	`NCT03497013` - Effect of tDCS on Cognition, Symptoms in Chronic Schizophrenia Patients With Tardive Dyskinesia	N/A